Disclosed is a composition of rosuvastatin calcium (present as 5 to 10 percent of the weight of the composition) not requiring tribasic phosphate salts for stability. The composition presents adequate bioavailability, useful in achieving a reduction in levels of lipids and/or cholesterol in the body, together with the method of manufacture of this composition.